Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Kosh Agarwal, Scott K. Fung, Tuan T. Nguyen, Wendy Cheng, Eric Sicard, Stephen D. Ryder, John F. Flaherty, Eileen Lawson, Sally Zhao, G. Mani Subramanian, John G. McHutchison, Edward J. Gane, Graham R. Foster

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection'. Together they form a unique fingerprint.

Medicine & Life Sciences